Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tail-anchoring of Proteins in the ER Membrane

Tail-anchoring of Proteins in the ER Membrane

Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Visible-Light-Induced Release of Carbon Monoxide: Multifunctionally Treatment for Dry Eye Disease.

Nano letters·2026

Same author

From materials to medicine: formulation-driven optimization and clinical prospects of NIR-II optical imaging agents.

Journal of materials chemistry. B·2026

Same author

Mucoadhesive Nanothalidomide Enema: Simultaneous Radioprotection and Barrier Repair in Radiation Enteritis Therapy.

ACS nano·2026

Same author

Intravascular Ultrasound-Guided Local Theranostics Enables Precise Treatment of Atherosclerotic Plaques.

ACS nano·2026

Same author

A biomimetic nanodisc system selectively activates type I interferons by nonclassical STING pathway for cancer immunotherapy.

Nature communications·2026

Same author

Cold atmospheric plasma-engineered nanovaccine with spatiotemporal sequential immunization reprograms antitumor immunity.

Science advances·2026

Search research articles

Related Experiment Video

Updated: Oct 21, 2025

In Vesiculo Synthesis of Peptide Membrane Precursors for Autonomous Vesicle Growth

In Vesiculo Synthesis of Peptide Membrane Precursors for Autonomous Vesicle Growth

Published on: June 28, 2019

Genetically Engineered Cellular Membrane Vesicles as Tailorable Shells for Therapeutics.

En Ren¹, Chao Liu¹, Peng Lv¹

¹State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, 361102, China.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)

|September 8, 2021

Summary

Biosynthetic cellular membrane vesicles (Bio-MVs) offer advanced therapeutic delivery due to their biocompatibility and unique structure. Genetically engineered Bio-MVs show promise for novel bio-nanotherapy applications.

Keywords:

cellular membrane vesicles genetically engineered tactics surface modification therapeutics carriers

More Related Videos

The Encapsulation of Cell-free Transcription and Translation Machinery in Vesicles for the Construction of Cellular Mimics

The Encapsulation of Cell-free Transcription and Translation Machinery in Vesicles for the Construction of Cellular Mimics

Published on: October 21, 2013

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

Related Experiment Videos

Last Updated: Oct 21, 2025

In Vesiculo Synthesis of Peptide Membrane Precursors for Autonomous Vesicle Growth

In Vesiculo Synthesis of Peptide Membrane Precursors for Autonomous Vesicle Growth

Published on: June 28, 2019

The Encapsulation of Cell-free Transcription and Translation Machinery in Vesicles for the Construction of Cellular Mimics

The Encapsulation of Cell-free Transcription and Translation Machinery in Vesicles for the Construction of Cellular Mimics

Published on: October 21, 2013

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

Area of Science:

Biotechnology
Nanotechnology
Drug Delivery

Background:

Biosynthetic cellular membrane vesicles (Bio-MVs) combine nanotechnology and biotechnology for therapeutic applications.
Bio-MVs possess a hydrophilic cavity and hydrophobic bilayer, offering biocompatibility and low immunogenicity.
Their cell-like properties and surface protein expression enable effective recombinant protein therapy and poly-therapy.

Purpose of the Study:

To review current technologies for Bio-MVs as therapeutic delivery systems.
To emphasize the multi-functionality of Bio-MVs as "tailorable shells" for delivering therapeutic agents.
To highlight successes and challenges in genetically engineered Bio-MVs for next-generation bio-nanotherapy.

Main Methods:

Discussion of established methods for Bio-MVs surface modification, including hydrophobic insertion and electrostatic interactions.
Focus on genetically engineering strategies for creating Bio-MVs with specific binding and protein expression.
Review of current progress in utilizing Bio-MVs for advanced therapeutic delivery.

Main Results:

Bio-MVs demonstrate superior characteristics for therapeutic transportation.
Genetically engineered Bio-MVs allow for controlled protein expression, binding specificity, and sorting.
Various tactics have been developed for surface modification and functionalization of Bio-MVs.

Conclusions:

Bio-MVs represent a promising platform for novel bio-nanotherapy.
Genetically engineered Bio-MVs offer a sustainable and facile approach to creating advanced therapeutic delivery systems.
Further research into Bio-MVs holds potential for significant advancements in poly-therapy and targeted drug delivery.